Myeloproliferative Neoplasms

Top Story

Second-line therapy for myelofibrosis remains ‘active area of research’

November 7, 2018

Four elected to ASH executive committee

October 29, 2018
Four individuals have been elected to American Society of Hematology’s executive committee. Their terms will begin after the ASH Annual Meeting and Exposition…

Eight researchers receive ASH bridge grants

October 27, 2018
ASH awarded $150,000 each to eight investigators through the society’s bridge grant program, designed to sustain promising hematologic research proposals that are…
FDA News

FDA grants priority review to Jakafi for acute graft-versus-host disease

October 26, 2018
The FDA granted priority review to ruxolitinib for the treatment of patients with acute graft-versus-host disease who have had an inadequate response to corticosteroids…
More Headlines »

Virtual NSCLC: Updates in Combining Immunotherapy with Other Treatment Modalities

This activity is supported by an educational grant from Merck & Co., Inc.

Lung cancer is a leading cause of cancer death worldwide. The American Cancer Society estimates that there will be…
More »
Meeting News

VIDEO: Takeda executive highlights research efforts in lung cancer, myeloma, myelodysplastic syndrome

June 19, 2018
More »

Ace the Case: A 52-Year-Old Man with an Asymptomatic Neck Mass

There is no commercial support for this activity.

This educational activity will discuss the approach to diagnosis and management of a 52-year-old man who presents with…
More »